People News: AstraZeneca and Pfizer

Share this article:

AstraZeneca hired Pfizer's Martin Mackay to lead research and development, and Pfizer named Wyeth R&D chief Mikael Dolsten to lead its R&D efforts. Dolsten, who led Wyeth R&D from May 2008 through the close of the company's acquisition by Pfizer, becomes president, Pfizer Worldwide R&D. Mackay, who was president, PharmaTherapeutics R&D at Pfizer, becomes president of R&D at AstraZeneca, with responsibility for delivering new drugs and biologics. Replacing him at Pfizer is SVP and head of worldwide research for PharmaTherapeutics R&D Rod MacKenzie, who will add responsibility for Asia R&D strategy to his current duties leading small molecule research.  

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in People Moves

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: October 20

Promotions and hires for agencies and manufacturers

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media